Buy McDonald's!: Ag...
Health Care: Drugs
Keryx Biopharmaceuticals Inc. (KERX: NASDAQ)
$3.46 0.01 | 0.29%
02/08/12 - 04:00 PM ET
895.68K / 1.06M
Vol / Avg. Vol:3.46 / 3.45
Open / Prev. Close:3.42 - 3.55
Today's Range:2.27 - 5.55
52 Wk Range:36.36%
Performance YTD:TheStreet Rating:
Portfolios with KERX
- Portfolio NameUser Type
- Contributor10 Biotech Stocks Loved and...
- UserStock rocks!
- Contributor11 Biotech Stocks Loved or ...
- UserFiuza 1
- ContributorStocks Under $5 With Most '...
- UserBioTech
- Userdaveduke
- UserMy CURRENT Watchlist~minus ...
- UserSUPRATRADE 7 Top Stocks for...
- UserASCO 2010
Latest KERX Headlines from TheStreet
- Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects 01.17.12 | 07:01 pm
- Biotech Stock Mailbag: Most Important Events for 2012 12.23.11 | 06:12 am
- Keryx Stock Hits New 52-Week Low (KERX) 12.13.11 | 03:12 pm
- Keryx Stock Hits New 52-Week Low (KERX) 11.25.11 | 12:11 pm
- 10 Biotech Stocks Loved and Hated by Wall Street's Top Investment Pros 11.15.11 | 06:11 am
- Biotech Stock Mailbag: Prostate Cancer Drug Reaction 11.04.11 | 05:11 am
- Biotech Stock Live Chat 10.20.11 | 11:10 am
- Keryx: Readers React to Perifosine Prediction 10.19.11 | 07:10 am
- Biotech Stock Mailbag: Keryx Pharma 10.14.11 | 06:10 am
- Keryx Pharma Loses Its Top Shareholder 10.11.11 | 01:10 pm
Press Releases for KERX
- Keryx Biopharmaceuticals To Present At 14th Annual BIO CEO And Investor Conference - PR Newswire 02.08.12 | 08:02 am
- Keryx Biopharmaceuticals To Present At JP Morgan's 30th Annual Healthcare Conference - PR Newswire 01.04.12 | 08:01 am
- Keryx Biopharmaceuticals Announces Phase 2 Data For KRX-0401 (Perifosine) In Hodgkin's Lymphoma Presented At ASH Meeting - PR Newswire 12.13.11 | 08:12 am
- Keryx Biopharmaceuticals Announces Highlights From Zerenex⢠(ferric Citrate) Poster Presentations At American Society Of Nephrology Kidney Week 2011 Annual Meeting - PR Newswire 11.14.11 | 08:11 am
- Keryx Biopharmaceuticals To Present At Lazard Capital Markets 8th Annual Healthcare Conference - PR Newswire 11.11.11 | 08:11 am
- Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations Of Zerenex⢠(Ferric Citrate) At The Upcoming American Society Of Nephrology Kidney Week 2011 Annual Meeting - PR Newswire 11.09.11 | 08:11 am
- Keryx Biopharmaceuticals, Inc. To Host Conference Call On Third Quarter 2011 Financial Results - PR Newswire 11.01.11 | 04:11 pm
- Phase 1 / 2 Clinical Trial Results Of KRX-0401 (Perifosine) Plus Bortezomib And Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma Published In The Journal Of Clinical Oncology - PR Newswire 10.13.11 | 09:10 am
- Journal Of Clinical Oncology Publishes Phase 2 Clinical Trial Results Of KRX-0401 (Perifosine) Plus Capecitabine In Patients With Metastatic Colorectal Cancer - PR Newswire 10.05.11 | 08:10 am
- Keryx Biopharmaceuticals Announces Completion Of Patient Enrollment In Zerenex⢠(Ferric Citrate) Phase 3 Long-Term Study - PR Newswire 09.19.11 | 08:09 am
Partner Headlines for KERX
- Stocks To Watch Week Of Feb. 6 - Seeking Alpha 02.06.12 | 08:02 am
- Notable Put Options Activity in Keryx Biopharmaceuticalskerx - Benzinga 01.30.12 | 01:01 pm
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Notable Put Options Activity in KLA-Tencor - Benzinga 12.06.11 | 01:12 pm
- Notable Put Options Activity in Keryx Biopharmaceuticals - Benzinga 12.06.11 | 01:12 pm
- Biotechs And Their Trials By Fire - Seeking Alpha 11.07.11 | 09:11 am
- Keryx Biopharmaceuticals: Volatility Could Potentially Produce Monetary Gains - Seeking Alpha 10.23.11 | 09:10 am
- 10 Stocks To Watch This Week - Seeking Alpha 10.16.11 | 09:10 am
